GB2206582A - Palatinose condensation product and a process for the preparation thereof and a method for utilizing the product - Google Patents

Palatinose condensation product and a process for the preparation thereof and a method for utilizing the product Download PDF

Info

Publication number
GB2206582A
GB2206582A GB08813095A GB8813095A GB2206582A GB 2206582 A GB2206582 A GB 2206582A GB 08813095 A GB08813095 A GB 08813095A GB 8813095 A GB8813095 A GB 8813095A GB 2206582 A GB2206582 A GB 2206582A
Authority
GB
United Kingdom
Prior art keywords
palatinose
condensation product
product
bifidobacterium
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08813095A
Other versions
GB2206582B (en
GB8813095D0 (en
Inventor
Yoshikazu Nakajima
Kohji Nishio
Takeo Mizutani
Kazuo Ogasa
Jun Kashimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui DM Sugar Co Ltd
Original Assignee
Mitsui Sugar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP63096870A external-priority patent/JP2704627B2/en
Application filed by Mitsui Sugar Co Ltd filed Critical Mitsui Sugar Co Ltd
Publication of GB8813095D0 publication Critical patent/GB8813095D0/en
Publication of GB2206582A publication Critical patent/GB2206582A/en
Application granted granted Critical
Publication of GB2206582B publication Critical patent/GB2206582B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/346Finished or semi-finished products in the form of powders, paste or liquids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/04COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing vitamins, antibiotics, other medicaments
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/06COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing beet sugar or cane sugar if specifically mentioned or containing other carbohydrates, e.g. starches, gums, alcohol sugar, polysaccharides, dextrin or containing high or low amount of carbohydrate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Saccharide Compounds (AREA)

Description

1 "PALATINOSE CONDENSATION PRODUCT AND A PROCESS FOR THE PREPARATION
THEREOF AND A METHOD FOR UTILIZING THE PRODUCT" is This invention relates to a palatinose condensation product which is obtained by the condensation of disaccharide palatinose, a process for the preparation of it and a method for utilizing it.
Palatinose, which is also called isomaltulose, is a disaccharide in which glucose and fructose are c-1,6 bonded, i.e. 6-o-p(-D-glucopyranosyl-fructofuranose.
Palatinose per se has been known for many years and is a glycide contained in honey in nature, and is obtained in industry by having glucosyltransferase act on sucrose (DE 3133128, UK 2082591 and US 4386158). Pala tinose has good quality of sweetness and good process ability for foods similar to those of sucrose, which makes it possible to use palatinose in foods generally.
Particularly because palatinose is non-cariogemic and anti-cariogenic, i.e. preventing cariogenicity of sucrose, the demand for palatinose has rapidly been increasing in recent years (DE 3142093, UK 2086203 and US 4556429).
Further a method is known for preparing a fructose condensation product by concentrating and then heating a solution of monosaccharide fructose at an acidic pH (Japanese Patent Application Laid-Open 86/271295).
This fructose condensation product is a sweetening. It is also known to utilize the fructose condensation product for proliferating Bifidobacterium (Japanese Patent Application Laid-Open 87/294081).
The present inventors have now prepared a palatin- 2206582 2 ose condensation product from disaccharide palatinose through condensation, and have found that the condensation product has properties very useful in the food industry.
It has now been found that when an aqueous palatinose solution having a pH of 3.2 to 5.8, preferably a pH of 3.5 to 4.4 is heat -concentrated up to a liquid temperature of about 105 to 1700C, palatinose condenses into a condensation product composed of 2 to 6, mainly 2 to 4, palatinose units.
The obtained palatinose condensation product is a novel compound and is found to be capable of being used instead of conventional thick malt syrup in foods to raise viscosity, to prevent freezing, to improve moisture retention in food, to attain a body effect and to suppress the proliferation of putrefying bacteria. The reaction mixture of palatinose condensation which contains a substantial amount of the palatinose condensation product may also be used as a substitute for conventional thick malt syrup.
Further, the palatinose condensation product is very useful to proliferate intestinal Bifidobacterium.
The process for the preparation of the palatinose condensation product and the resulting condensation product will now be described.
The condensation reaction is greatly influenced by the pH, temperature and concentration of the aqueous palatinose solution. The reaction is facilitated by higher temperature, lower pH and higher concentration.
When these factors are in conditions such as to strongly facilitate the reaction, the formation of the palatinose condensation product increases, and also increased are a degradation product and monosaccharide 1 3 formed by decomposition of palatinose, and a trisaccharide-corresponding product which seems to be a condensation product of these with palatinose.
The palatinose condensation product is colourless and has considerably low sweetness, while the degradation product formed by decomposition of palatinose has bitterness. Accordingly, when a reaction mixture of the palatinose condensation reaction is used as such, i.e. without isolating the condensation product, in foods, it is preferred to adjust condensation reaction conditions so as to suppress the formation of the degradation product below a certain amount,. preferably 0.45 wt.% or less, or to remove the degradation product from the condensation reaction mixture with an exchange resin. The bitterness may be eliminated by adding an alkaline substance to the reaction mixture to make it neutral or alkaline. However, discolouring becomes noticeable.
It has now been found that it is preferred to conduct the heat condentration in reduced pressure conditions, particulaly about 110 mmHg (absolute, hereinafter the same) or below, for a relatively short time in order to suppress the formation of the degradation product. The heating time depends upon the apparatus used, but is generally 1 to 60 minutes. it is preferred to continue the concentration until the water content becomes 1 to 5% by weight. The liquid temperature at the end of the reduced-pressure concentration should be about 105 to 1700C, preferably 105 to 1600C, particularly 130 to 1600C. For instance, a concentrator of the spirally des,ending thin film type or an evapora4L--or of the continuous concentration type is suitable for use in the reduced-pressure 4 concentration procedure, where the contact time of the feed with the heating surface is short.
The heat concentration can however be carried out at normal pressure. Generally, it is necessary to raise the liquid temperature up to high temperatures of 140 to 1650C in order to attain a water content suitable for the condensation reaction. Further, the heating time is also relatively long. Therefore, the palatinose degradation product is formed in a larger io amount. A method of raising the temperature by the use of a plate type heat exchanger and flashing the liquid is advantageous in that the time for which the liquid is maintained at high temperatures is short, but the degree of concentration is insufficient and the water content in the liquid is relatively high, so that the condensation reaction tends not to proceed sufficiently.
Further, it may be thought to use an extruder as a pressurizing melting method, but this is however disadvantageous in the formation of the degradation product. Any of these methods may cause the condensation reaction of palatinose.
A palatinose solution in water shows a pH value around 5.8. The condensation reaction of palatinose is facilitated by acid catalysts. Therefore, an acid is preferably added to the starting palatinose solution in water to adjust the pH to about 3.2 to 5.8, preferably 3.5 to 4.4. The acid to be used is not particularly restricted, but those used generally in foods may be preferably used, for instance less volatile organic acids such as citr--3 acid, malic acid, succinic acid and tartaric acid. Citric acid is particularly preferred because its catalytic activity is relatively high and the amount of the resulting degradation product is less. More volatile organic acids such as acetic acid will vaporize into air during the concentration process and therefore have to be replenished, which is unfavourable in operation. Inorganic acids such as hydrochloric acid, phosphoric acid and sulphuric acid show a little worse reproducibility of the reaction compared to the organic acids, which leads to unstable quality of the product. Therefore, the inorganic acids are not always preferred. Two or more acids may be used together.
The concentration of palatinose in the starting aqueous palatinose solution is not particularly restricted, and may be in a range where palatinose is substantially completely dissolved during the heating.
Too low concentrations require a prolonged time period of the concentrating operation and thereforeare disadvantageous. In general, concentrations of about to 80% by weight are preferred.
After the condensation reaction is conducted as explained above.. a reaction mixture with a solid content of 95 to 99% by weight is obtained. The reaction mixture contains tetra- to dodeca- saccharide, mainly tetrato octa-saccharide, resulting from condensation of 2 to 6, mainly 2 to 4, palatinose units generally in an amount of 10 to 70% by weight. Monosaccharide resulting from the decomposition of disaccharide palatinose, trisaccharide-corresponding products which are thought to be caused by the' conden- sation of palatinose with the above monosaccharide or with its derivatives in which the ring is opened (hereinafter referred to simply as trisaccharide) and the degradation product are formed generally in an 6 amount of 20% by weight or less in all. Further, unreacted palatinose remains therein, of course.
The properties and utilization of the palatinose condensation product Of the invention will now be described.
The palatinose condensation product of the invention has much lower sweetness than that of sucrose and, even, that of palatinose. This condensation product reverts to palatinose upon hydrolysis and, therefore, is non-cariogenic and anti-cariogenic like palatinose. Accordingly, the palatinose condensation product may be used to modify texture, etc. of foods without changing the sweetness of the foods to which it is added and is particularly useful in foods character- ized by non-cariogenicity or anti-cariogenicity. Above all, it exhibits a special effect when it is used in foods in which palatinose is contained as a sweetening. That is, palatinose is less soluble compared to sucrose, which limits the use of palatinose. For instance, it is impossible to produce jam, sweet jelly of beans, hard jelly or caramel due to the precipitation of palatinose crystals called "revertion" or lygritty". In order to prevent "revertion" or "gritty", it may be thought to add sorbite, hydrolised starch, reduced maltose syrup, sucrose, coupling sugar or the like. However, in such a method, the amount of palatinose contained in confectionery is decreased inevitably and, then, such confectionery cannot be described as having less cariogenicity or as being non- cariogenic. It has now been found that when the palatinose condensation product of the invention is used together with palatinose in foods, precipitation of palatinose crystals may be inhibited or prevented and 7 such foods can be described as low cariogenic foods.
When the palatinose condensation product is used together with palatinose according to the invention, it is not always necessary to separate the palatinose condensation product from the palatinose condensation reaction mixture. It is possible to use a reaction mixture as a whole which contains unreacted palatinose, trisaccharide, etc. besides the palatinose condensation product (hereinafter referred to as a product mixture), wherein the remaining palatinose may be taken into consideration in a recipe. In such a case, it is generally recommendable to use a product mixture which contains a less amount, e.g. 0.45 wtA or less, of the aforesaid bitter degradation product, though the numeric value, "0.45 wt.%". is merely illustrative because bitterness depends also upon the amount of the product mixture added to a food.
Further, the palatinose condensation product or the product mixture according to the invention may be used as a substitute for conventional malt syrup. That is, these materials have the effect of raising the viscosity, preventing freezing, improving moisture retention in food, attaining a body effect and suppressing the proliferation of putrefactive bacteria.
The palatinose condensation product of the invention is also very usetful as a substance enhancing the proliferation of Bifidobacterium, which will be explained below.
A lot of bacteria inhibit the human intestines soon after birth. The number of bacteria living in intestines of a single person is 10x14 or more and the number of the species of the bacteria is almost 100. These repeat the proliferation making use of the 8 contents of the intestines as nutrients to establish intestinal flora while keeping a certain balance. Anaerobic bacteria such as Bacteroidaceae, Eubacterium and anaerobic Streptococcus, and Bifidobacterium important as human lactic acid bacterium are known as dominant bacteria in adult intestines. Those bacteria inhabit the intestine whilst keeping a balance among themselves. Recently, a method of cultivating the intestinal bacteria was developed and, accordingly, researches on the intestinal bacteria have actively been made to find that some of those intestinal bacteria are useful to a host and some others enter into the tissue of a host to cause damage to it or produce noxious substances. Thus, the intestinal bacteria have been drawing attention. The number of enzymes born by the intestinal bacteria is said to be larger than that of enzymes of a liver. It is also said that the intestinal bacteria have great influence on human bodies and the intestinal flora even may effect whethera person is healthy. Bifidobacterium is known as a physiologically favourable bacteriaum effective to maintain health, which always inhabit the intestines of infants and adults and show antagonistic action against the proliferation of putrefactive bacteria, prevention of intestinal absorption of noxious substances, enhancement of immunological functions and improvement of metabolism of vitamins. Further, this bacterium is said to have a close relationship with aging. In order to make efficiefit use of such usefulness of Bifidobacteriumf it is desired to always maintain Bifidobacterii-,-,i at a high level in intestines, and medicaments and foods containing Bifidobacterium are now available on the market.
i 9 Temporary increase of Bifidobacterium can be attained by orally administering Bifidobacterium continuously. However, if the administration is stopped, it is eliminated from the body for a short time and the desired effect is not attained. Then, it has been thought important to create environments where Bifidobacterium stays and proliferates, and some attempts have been made to maintain the number of the intestinal Bifidobacterium at a high level by orally administering a substance which enhances the proliferation of Bifidobacterium. Recently, a factor most necessary for Bifidobacterium to proliferate in inte. stines was thought to be saccharide as an energy source, and it was in fact found that Bifidobacterium could exploit raffinose, stachyose, inulin etc. among oligosaccharides and polysaccharlldes. Based on this fact, it was proposed that lactulose, raffinose, stachyose, inulin, fructooligomer, isomaltooligomer, galacturose and galactooligosaccharide are effective to proliferate Bifidobacterium in host intestines. However, some of these saccharides show poor assimilation by Bifidobac terium and some others exhibit a poor effect on Eifido bacterium in practical administration to a human being, or lack selectivity to intestinal bacteria being exploited by unfavourable intestinal bacterium as well as Bifidobacterium, or generate gas extraordinarily.
Therefore, it has been needed to develop a useful saccharide source which is specifically utilized by Bifidobacterium and has no side effects.
It has now been found that the palatinose conden sation product is very eff-,ctive to selectively enhance the proliferation of Bifidobacterium, which is another aspect of the invention.
comprising the palatinose condensation product in an effective amount.
The composition according to the invention includes any of the product mixture per. se which is prepared as described above and contains 10 to 70 wtA of the palatinose condensation product, or foods, drinks or medicaments or their raw materials to which the palatinose condensation product or the product mixture is admixed. Preferably, the palatinose conden- sation product is contained in the composition useful in the proliferation of Bifidobacterium in an amount of about 0.5 to 80% by weight, particularly about 1 to 70% by weight. If it is less than about 0. 5% by weight, the effect on the proliferation of Bifidobacterium is poor. On the other hand, an amount more than about 80% by weight does not cause any particular problem. However, when it is utilized in foods, there is some limitations from the viewpoint of taste and production process and the amount is about 70% by weight or less in general.
The-invention may be put into practice in various ways and a number of specific embodiments will be described by way of example to illustrate the invention with reference to the accompanying drawings, in which:
Figures 1 and 2 are high performance liquid chromatographs of a palatinose condensation reaction mixture with different columns; Figure 3 is a high performance liquid chromato graph of a hydrolyed reaction mixture; Figures 4 and 5 are graphs of conversions of pala tinos,-- and yields of the condensation product, respectively, at different amounts of citric acid and different temperatures; and 11 Figure 6 is a graph showing compositions of the reaction mixtures at different temperatures.
In the Examples, "%" and "part" means weight percent and weight partr respectively, unless otherwise stated.
EXAMPLE 1 Preparation of the palatinose condensation product.
A hundred (100) parts of crystalline palatinose and 0.01 part of anhydrous citric acid were added to 33 parts of boiling water and heated to 1050C with stirring to dissolve the materials. The mixture was then heated to 1500C within 1 minute under a pressure of 60 mmHg in the heating tubes of a vacuum continuous evaporator and, then, subjected to the concentration and reaction for about 3 minutes in the vacuum evaporator. Subsequently, it was solidified into pieces of 6g apiece with a stamping machine and crushed with a crusher. The resulting product containing the palatinose condensation product had the following composition.
The resulting product had a solid content of 99.0%, pH of 4.2 and a colour value of 31 in ICUMSA units, and exhibited no bitterness and a little sweetness. The resulting product was subjected to high performance liquid chromatography as stated above and was found to contain 44.3% of the palatinose condensation product, provided that the water contained was not taken into the calculation of composition.
Analysis of the composition of the obtained reaction mixture will be described. The reaction mixture was subjected to high performance liquid chromatography under the following conditions.
12 1 2 3 4 5 6 7 was subjected to high performance liquid chromatography under the following conditions. Column: Shodex Ionpak KS-802 Moving phase: water Flow of the moving phase: 1 ml/min. Detector: Differential refractometer Sensitivity of the differential refractometer 16 x Chart speed: 0.5 cm/min. Temperature: 800C Concentration of the sample: 5 w/v % Injected amount: 25 microlitre. Figure 1 is the chromatograph which was obtained.
The following Table 1 gives the species corresponding 15 to the retention time of each peak and its amount. TABLE 1 Retention Peak No. time 5.824 6.053 6.449 7.249 8.135 8.480 9.410 Species palatinose condensation product octasaccharide ditto hexasaccharide ditto tri- and tetrasaccharide palatinose glucose fructose degradation product Amount 5.0 11.5 30.6 52.2 0.2 0.2 0.3 In Figure 1, the fractionation between trisaccha ride and tetrasaccharide is insufficient (peak No. 3).
Because of this the same sample was then subjected to high performance liquid chromatograph under the follow ing conditions which were suited to this fractionation 13 but insufficient for the fractionation of monosaccharides.
Column: ERC-NH-1171 (Elmor Optics Co.) Moving phase: acetonitrile/water = 63/37 Flow of the moving phase: 1 ml/min.
Detector: Differential refractometer Sensitivity of the differential refractometer:
16 x Chart speed: 0.5 cm/min.
Temperature: 250C Concentration of the sample: 5 w/v % Injected amount: 25 microlitre.
Figure 2 is the chromatograph which was obtained.
The following Table 2 gives the species corresponding to the retention time of each peak and its amount.
TABLE 2
Retention Peak No. time 1 6.270 2 6.963 3 8.596 4 5 6 8 9.870 12.950 14.050 19.470 20.830 Species monosaccharide palatinose palatinose condensation product trisaccharide ditto tetrasaccharide ditto hexasaccharide ditto hexasaccharide ditto octasaccharide ditto octasaccharide Amount 0.4 54.0 3.0 29.8 4.0 7.3 0.9 0.6 From the above, it was found that the ratio of the trisaccharide to tetrasaccharide was about 1 to 10.
Accordingly, by proportionally dividing the p.ak No. 3 in Table 1, the following composition given in Table 3 can be deduced.
14 TABLE 3
Species Palatinose condensation product octasaccharide ditto hexasaccharide ditto tetrasaccharide ditto trisaccharide Palatinose Glucose Fructose Degradation product Ratio -M 5.0 11.5 27.8 2.8 52.2 0.2 0.2 0.3 Thus, the sample contained 44.3% of tetra- to octasaccharide of the invention.
is Next, the heat concentration product was subjected to hydrolysis and analysed. That is, a solution in water was prepared with a solid content of 5% of the heat concentration reaction mixture obtained in Example 1 above, to 10 ml of which 1 ml of 1 N hydrochloric acid was added, heated at 800C for 15 minutes and neutralised. The resultant product was subjected to high performance liquid chromatography on the same conditions as those of the aforesaid Shodex lonpak KS 802 used to produce Table 1.
The chromatograph as shown in Figure 3 was obtained.
The following Table 4 gives the species corresponding to each peak and its amount.
is TABLE 4, is Retention Peak No. time Species Amount % 1 6.454 palatinose condensation 2.9 product trisaccharide 2 7.254 palatinose 96.0 3 8.140 glucose 0.4 4 8.485 fructose 0.4 9.415 degradation product 0.3 It is clear that the palatinose condensation product of the invention change mostly into palatinose by hydrolysis.
EXAMPLE 2
Preparation of the palatinose condensation product.
A hundred (100) parts of crystalline palatinose and 0.02 part of anhydrous citric acid were added to 33 parts of boiling water and heated to 1050C with stirring to dissolve the materials. The mixture was then boiled down under a pressure of 60mmHg in a vacuum concentrate until the temperature of the concentrated reached 1500C for 35 minutes. Subsequently, the heating was stopped and the product was solidified into pieces of 6g apiece with a stamping machine and crushed with a crusher.
The resulting product had a solid content of 99.0%, pH of 4.0 and a colour value of 88 in ICUMSA units.
High performance liquid chromatography gave the following composition. wherein the percentages were calculated neglecting the water contained in the 16 concentrated product. Palatinose condensation product Palatinose Trisaccharide Monosaccharide Degradation product 70.8% 22.1% 6.0% 0.6% 0.5% This product mixture had slight bitterness and pale yellow discolouring and could be used in any foods.
EXAMPLE 3
Preparation of the palatinose condensation product.
A hundred (100) parts of crystalline palatinose and 0.05 part of anhydrous citric acid were added to 33 parts of boiling water and heated to 1050C with stirring to dissolve the materials. The mixture was then subjected to reaction under a pressure of 60 mmHg as in Example 1. Subsequently, it was solidified into pieces of 6g apiece with a stamping machine and crushed 20 with a crusher.
The resulting product had a solid content of 99.1%, pH of 3.8 and a colour value of 30 in ICUMSA units, and exhibited almost no bitterness. The composition was as follows, wherein the water was not taken into the calculation.
Palatinose condensation product 66.6% Palatinose 28.9% Trisaccharide 3.6% Monosaccharide Degradation product 0.5% 0.4% 17 EXAMPLE 4
Preparation of the palatinose condensation product.
A hundred (100) parts- of crystalline palatinose were added to 33 parts of boiling water and concentrated with stirring for about 10 minutes at normal pressure in a copper pan until the temperature of the contents reached 1600C. It was then solidified into pieces of 3g apiece with a stamping machine.
In the present Example, the heat concentration was carried out at atmospheric pressure, and the concentration was set relatively short to lower the amount of the degradation product.
The resulting product had a solid content of 97.0%, pH of 4.3 and a colour value of 287 in ICUMSA units, i.e. considerable discolouration, and exhibited almost no bitterness and a taste like a candy made of heat-melted crystal sugar. The composition was as follows, the water contained in the resulting product not being taken into account in the calculation.
Palatinose condensation product 18.1% Palatinose Trisaccharide Monosaccharide Degradation product 77.7% 2.9% 1.0% 0.3% EXAMPLE 5
Preparation of the palatinose condensation product.
Thirty (30) kg of crystalline palatinose and 9 kg of water were placed in a 50 1 stainless steel vessel and heated to 1050C with stirring to dissolve the materials. The whole amount of this palatinose solu- 18 tion in water was transferred to a vacuum cooker with a stirrer, to which 3.0 g of anhydrous citric acid were added and the mixture stirred. The pH of the aqueous palatinose solution at this stage was 4.1. Then, the pressure was reduced to 60 mmHg and the content was concentrated with heating. It took 30 minutes for the temperature of the concentrated liquid to reach 1350C. At the moment when the temperature reached 1350C, the heating was stopped. The resulting product had a solid content of 98% and the following composition, the water contained in the resulting product not being taken into account in the calculation.
Palatinose condensation product Palatinose Trisaccharide Monosaccharide Degradation product 53.4% 42.0% 3.6% 0.6% 0.4% EXAMPLE 6
This was a batch process. 15 Kg of a 75 wt.% palatinose solution in water were placed in a 20 1 stainless steel kettle concentrator with a stirrer used in the production of hard candy. A final heating temperature was selected in the range of from 1000C to 1700C with an interval of 100C. The amount of citric acid was 0%, 0.001%, 0.01%, 0.1% or 1.0% by weight. In every case, the pressure was 50 mmHg and the heating time was about 25 to 30 minutes. The results are as shown in Figures 4 and 5. In Figure 4, the ordinate is percentage decrease of palatinose, i.e. conversion, and the abscissa is the amount of citric acid -dded in percentage calculated on the solid. In Figure 5, the ordinate is the amount of the formed palatinose conden- 19 sation product, i.e. yield, and the abscissa is the amount of citric acid added. In each group of the bars, the final heating temperature was 170, 160, 150, 140, 130, 120, 110 and 1000C from the right-hand most bar to the left-hand most. In the case were bars on the lower temperature side are not seen, this means that the resultant numeric values were nearly zero. The larger the amount of citric acid added and the higher the reaction temperature, the larger was the conversion of the palatinose. The yield of the condensation product was largest when the amount of citric added was 0.01% and the temperature was 150 to 1600C. However, it is difficult in these conditions to suppress the formation of discolouring components and bitter components. Accordingly, a preferred final heating temperature under the above reaction conditions is 1400C.
EXAMPLE 7
In this example a continuous vacuum evaporator was used. A palatinose solution in water was fed with a quantitative pump from a tank to vacuum heating tubes in which the solution was retained for about 1 minute, and then transferred to a vacuum evaporator in which the solution was retained for about 3 minutes. In the vacuum heating tubes, the aqueous palatinose solution flowed through the tubes and the outer wall of the tubes was heated at a predetermined temperature in the range of 125 of 1500C with high pressure steam. The concentration temperature in the vacuum evaporator was lower than the temperature of the vacuum heating tubes by about 100C when the latter xceed 1300C or by about 60C when the latter was 1300C or below. In every case, the amount of citric acid was 0.01% by weight and the pressure was 50 mmHg. The results are as shown in Figure 6, where the ordinate is the content (% by weight) and the abscissa is the heating temperature of the vacuum heating tubes. The uppermost curve corresponds to palatinose in the heat concentration product; the middle the palatinose condensation product; and the lowest, to the total of thedegradation product, the monosaccharide and the trisaccharide.
The amount of the condensation product formed was smaller in the continuous vacuum evaporator than that in the aforesaid batch mode where the heating time was 25 to 30 minutes, but the total amount of the degradation product, the monosaccharide and the trisaccharide which were formed was as very small as 4%, compared to that in the batch mode. Therefore, there is room to increase the amount of condensation product formed by raising the reaction temperature or by increasing the amount of organic acid added.
EXAMPLE 8
Preparation of palatinose hard jelly.
The sugar content is as high as 80% in a usual recipe of hard jelly. However, because palatinose crystallises easily, it was impossible to produce hard jelly containing it at such a concentration. Thus we have tried to produce palatinose hard jelly utilizing the palatinose condensation product.
The product mixture containing the palatinose condensation product used here was that obtained in Example 3 (solids content 99.1%). The used palatinose syrup was a syrup left after the crystallization of palatinose from a crude reaction mixture obtained by converting sucrose to palatinose with enzyme, the composition of which was as follows.
21 Composition of the palatinose syrup Solid 71.1% Glucose 10.5% Fructose 9.2% Sucrose 2.5% Palatinose 13.8% Trehalulose 28.0% Isomaltose 3.7% Other saccharides 3.4% The blending ratio of raw materials tinose hard jelly was as follows.
Material Blended Anhydrous citric acid Pectin (super slow set Sag.150) 15 Powdery palatinose Product mixture (from Ex. 3) Palatinose syrup Flavour Colourant 20 Water 1 1 for the pala- amount (part) 14 22 50 834 616 little little 322 Preparation.
The pectin and the powdery palatinose were mixed, transferred to a vacuum cooker and dissolved in water, which was then boiled over a fire and, subsequently, a sufficient vacuum was formed. The palatinose syrup and the product mixture were sucked through the sucking nozzle, and boiled down until the solid content became 80%. The vacuum was released and the heating was stopped, and then the 50% citric acid solution in water was added with vigorous stirring, followed by the addition of the flavour and the colourant. The mixture was poured into a mould.. After cooling, the jelly was 22 taken out of the mould, and crystalline palatinose was sprinkled on the jelly to produce a final product.
No crystallization was observed after this jelly was stored at room temperature for one month. Furtherr the taste was also excellent with rather low sweetness, and excellent texture and body. Accordingly, it is possible to produce excellent hard jelly using the palatinose condensation product of the invention instead of conventional malt syrup, and such jelly is less cariogenic and anti-cariogenic. EXAMPLE 9 Preparation of palatinose ice cream.
In general, sugar in ice cream often crystallizes during distribution to create an unfavourable texture.
If palatinose is used, it is very difficult to prevent the crystallization because of its low solubility. In order to solve this problem, a palatinose ice cream has now been prepared using the palatinose condensation product. The product mixture and palatinose syrup used were the same as those used in Example 8. The blending ratio was as follows.
Material Amount (-part) Milk (fat 3.5%) 40.0 Cream (fat 40%) 18.0 Nonfat milk powder 6.o Product mixture 15.0 Palatinose syrup 7.0 Emulsifier 0.3 Stabilizer 0.3 Flavour a little Water 15.4 Preparation.
The stabilizer and the emulsifier were dissolved 1 1 t 1 i 1 f 1 1 23 is in water in a pasteurizer and heated to 700C, followed by the proper addition of the remaining materials. This was then passed through a pressurized homogenizer and stored in a refrigerator. It was then placed in a freezer at -70C, filled in cups and solidified in a solidifying vessel. The resulting product was subjected to a severe treatment test where the temperature was raised and lowered between -250C and -30C five times in 5 days. Precipitation of palatinose crystals was not observed. It was a good quality ice cream with plain and simple sweetness.
EXAMPLE 10
Preparation of palatinose chewing gum.
In general, the amount of sugar in chewing gum is preferably from 0.1 to 3.9 times by weight to a gum base, and from 10 to 100 times to flavour for the continuation and buildup of flavour. However, if palatinose alone is used in chewing gum, viscoelasticity becomes insufficient resulting in damage to the texture. Therefore, a chewing gum has now been prepared in this Example by substituting the product mixture obtained in Example 1 for a part of the palatinose. The blending ratio was as follows.
Material Amount (part) Sugar ester 20 Ester gum resin 100 Vinyl acetate 120 Wax 80 Peppermint flavour 10 Powdered palatinose (200 mesh) 450 Product mixture 150 Glyceride 30 i 24 Talc Preparation.
The above materials were mixed at 900C and, after cooling, rolled and shaped into palatinose chewing gum of 3 g apiece. The chewing gum obtained had a continuing flavour and desirable texture.
When only palatinose was used as the saccharide, the upper limit of its amount for good viscoelasticity was 2 times by weight on the gumbase. Howeveri it became possible to use a larger amount of palatinose by the aid of the palatinose condensation product as in the present Example.
EXAMPLE 11
Bifidobacterium proliferation test with the palatinose condensation product.
From 29 volunteers, 8 persons who had a less quantity of Bifidobacterium in intestines were selected for the test. The eight volunteers were subject to restrictions on medicines and foods affecting intestinal flora during the experiments. The time period of the experiment was 40 days. In the first ten days, the composition useful for the proliferation of Bifidobacterium was not administered; in the 11th to 20th days, 4 candies (12 g) obtained in Example 4 containing 17.6% (= 18.1 x 0.97) of the palatinose condensation product were administered per day; in the 21st to 30th days, 8 candies (24 g) were administered per day; and in the remaining 10 days, no administration was conducted again. In every administration period, faeces of the volunteers were sampled every fi.e days and tested for the number of intestinal bacteria and their occupation ratios twice in every period. Table 5 shows the number Of bacteria in the unit Of the number intestinal bacterium Table 6 (common 1Ogarith.)/g Of each Shows the Occupation ratio.
and Other main bacteria faeces.
of Bifidobacterium in the faeces to the total number Of bacteria the subjects. These results are average Of all Table 5 Number of Bacteria Bacterium Enterobacteriaceae Streptococcaceae Staphylococcus Yeast Corynebacterium Bacillus Lactbacillus Bifidobacterium Eubacterium Bacteroidaceae Peptococcaceae C. perfringens Veillonella Other Clostridia Megasphaera Total Before administration 7.0-t 0.8 7.4 1. 5 3.0 0.7 3.5 0. 9 5. 5 1.1 2.6 0.3 5.6t 1.7 9.5 0.3 9.9 0.3 10.8 0.2 9.8 0.4 4. 7 t 0.5 5. 7t 1.7 7.2 1.2 8. 2 0.8 10.9 0.2 Administration of 12 g 7.0 1.0 7. 2 1. 5 3.6 1.0 3.3 0. 7 2.3 6.0 1. 4 9.8 0. 4 10.0 0.4 10. 8 0. 2 9. 4 0.5 4. 7 2.0 4.8 1. 2 6. 4 2.1 8.6 0.3 10. 9t 0. 2 Administration After suspension of of 24 g administration 7.1 1.1 7.2 0.9 7.6 1.3 7.3 1.1 3.3 1.2 2.9 0.5 2.9 0.5 3.0 0.6 4. 3 1. 7 6. 1 2. 0 10.0 0. 4 9.8 0. 5 10. 8 0. 2 9. 6 0. 3 4. 1 1. 9 4.8t 1.6 7.3 1. 1 8. 9 0. 6 10.9 0. 1 4. 2t 1. 9 6.3 t 1.8 9. 6 0.5 9. 8 0.8 10.8 0.2 9. 2 t 0.8 5.3+_0.9 4. 5 1. 4 7. 4 1. 2 8. 7 0. 6 10. 8 t 0. 2 ,j G Table 6 Occupation Ratio of Main Bacteria Bacterium Before Administration Administration After suspension of administration of 12 g of 24 g administration Bifidobacterium 4.0 % 7.9 Yo 12.9 % 6.3 % Bacteroidaceae 77.5 % 75.8 % 73.5 % 80.6 % Eubacterium 10.0 %.1-2.5 % 7.9 % 10.0 Peptococaceae 7.9 % 3.2 % 5.1 % 2.5 % i 1 28 During the period of administration of the palatinose condensation product, the number of Bif idobacterium and its occupation ratio increased in seven persons out of the eight volunteers. The increase in the number of Bifidobacterium in comparison with that before the administration is statistically significant at the level of significance of 5% in the period of administration of 12 g, and at the level of significance of 1 % in the period of administration of 24 g.
io The increase in the occupation ratio in comparison with that before the administration is statistically significant at the level of significance of 5% in the period of administration of 24 g. On the other hand, almost no change was observed in the other bacteria, and some bacteria show even a tendency of decrease. As the administration was suspended, the number of Bifidobacterium and its occupation ratio decreased. These results show that the palatinose condensation product specifically enhances the proliferation of Bifidobac- terium.
EXAMPLE 12 Bifidobacterium proliferation test with palatinose condensation product.
Because Example 11 showed that the palatinose condensation product had the effect to enhance the proliferation of Bifidobacterium, further experiments were conducted on the seven volunteers of Example 11.
Four candies (24 g) obtained in Example 1 containing 43.9% (= 44.3 x 0.99) of the palatinose condensation product were administered according to the same manner as in Example 11. In every administration period, faeces of the volunteers were sampled and tested for the number of intestinal bacteria and their occupation ratios in the similar_manner as in the above.
Table 7 Number of Bacteria Bacterium Enterobacterlaceae Streptococcaceae Staphylococcus Yeast Corynebacterium Bacillus LactbacIllus Bifidobacterium Eubacterium Bacteroidaceae Peptococcaceae C. perfringens Veillonella Other Clostridia Megasphaera Total Before administration 7.3 1.6 7. 1:t 1. 3 3.2 0.6 3.6 0.6 4.0 1.9 6. 5 1. 4 9.3 1.4 10.1 0. 5 10. 7 0. 2 9.4 0.4 4.7 0.9 5. 5 1. o 7.3 2.4 8.3 0.0 10.9 0. 2 Administration After suspension of of 24 g administration 7.4 1.4 7.5t 1.4 7.6 1.0 7.3 1.3 3.6 0.7 3.3 0.3 5.1 0.9 5.8 1.9 9.8 0. 9 10.0 0.4 10.6 0.2 9. 2 0.7 4. 7 0.7 5. 4 1.6 8.3 1.0 8.5 0.3 10.9t 0.2 3.1 0. 7 2.9 0.4 7.3 t 0.0 2.5 0.1 5.6.t 1.0 9.1 1.0 10. 2 0.3 10.7 0. 2 9. 4 0.3 5.7 1. 2 5.1 1.6 8. 2 1.0 7. 7 0.7 10.9t0.2 i i r) Table 8 Occupation Ratio of Main Bacteria Bacterium Before Administration After suspension of administration of 24 g administration Bifidobacterium. 5.5 % 23.3 % 8,6 % Eubacterium 21.8 % 17.9 % 23.9 % Bacteroidaceae 65.5 % 52.5 % 62.3 % Ili j Peptococaceae 2.9 % 4.0 % 3.0 % 1 0 31 In these experiments, the number of Bif idobacterium and the occupation ratio increased in six volunteers out of the seven volunteers during the period of administration of the palatinose condensation product.
Particularly in five volunteers among them, the effect on the proliferation of Bifidobacterium was remarkable. The increases in number of Bifidobacterium and its occupation ratio during the administration in comparison with those before the administration were statist- ically significant at the level of significance of 5%. on the other hand, other major occupying bacteria, Bacteroidaceae and Eubacteriumt showed the decreases in number and occupation ratio. The above results show that the palatinose condensation product is saccharide which is selectively assimilated by Bifidobacterium. but difficulty assimilated by other bacteria. That Bifidobacterium proliferates and, meanwhile, putrefactive bacteria decrease leads to the decrease of adsorption of ammonia noxious to a human body and the decrease of production of carcinogenic substances such as amines, phenols and indoles.
EXAMPLE 13 In-vitro test In order to confirm the above results, a saccharide assimilation test by intestinal bacteria was conducted in vitro, where the fractionated palatinose condensation product was used instead of the product mixture.
The palatinose condensation product fractionated by chromatography was added in an amount of 5% to a 10% nonfat milk medium containing a pH indicator and homogeneously dissolved. A solution containing each of the intestinal bacteria was dropwise added to each medium, 32 covered with 2.5 ml of liquid paraffin and incubated at 370C. The extents of the prolif eration of Bif idobacterium and the other intestinal bacteria were determined by observing the change in colour of the indicator, from which the ability to assimilate the saccharide was judged. Besides,, anaerobic incubation on the same media containing the palatinose condensation product was conducted in an anaerobic jar charged with carbon dioxide gas, and the change in pH of the media was observed.
Also in this test, the palatinose condensation product was well assimilated by Bifidobacterium adoles centis, Bifidobacterium longum, Bifidobacterium infantis and Bifidobacterium bifidum, but with other intestinal bacteria were clearly different in ability of the assimilation. That is, it has been found that only Bifidobactirium has high ability of exploiting the saccharide.
EXAMPLE 14
Preparation of hard candy.
Each of the product mixtures obtained in Examples 2, 1 and 4 above was admixed with 1 % of lyophilized black tea powder and 0.3% of an oil flavour on a cooling plate, which was moulded into hard candies of 3g apiece with a stamping machine.
These were subjected to an organoleptic test by fifteen panellists. The results are as follows.
Palatinose condensation Best physical Best Strongest product from properties taste sweetness Example 2 4 0 0 Example 1 11 10 2 Example 4 0 5 13 A 33 EXAMPLE 15
Preparation of hard jelly.
In the preparation of pectin hard jelly, the addition of the palatinose condensation product of 10to 70%, based on the whole saccharide, makes the viscosity increase and gives hard jelly of good quality. A hundred parts of hot water were added to 80 parts of a mixture of pectin (slow set Sag.150) and powdered sugar (1:9), and the pectin was completely dissolved while heating. Granulated sugar and each of the product mixtures of Examples 2, 1 and 4 were mixed so that the weight ratio of the granulated sugar to the palatinose condensation product was 1:3, 1:1 or 3:1.. Four hundred parts of each of the mixtures were added to the above solution to dissolve, and the heating was stopped. Then, a small quantity of a flavour and a colourant, and 2 parts of citric acid were added, and the mixture was then poured into a mould.
The product was subjected to an organoleptic test by fifteen panellists.' The results are as follows.
1 Palatinose condensation 1: 3 1: 1 3: 1 product from Taste Appearance Taste Appearance Taste Appearance Example 2 good slight slightly discoloring bitter dAscoloring discoloring bitter Example 1 good no good no good slight discoloring discoloring discoloring Example 4 good no good slight. good discoloring discoloring iscoloring 1 1 1 1, U'j --F EXAMPLE 16
Preparation of refreshing drink.
In the preparation of a refreshing drink suitable to be mixed with Shochu (a kind of distilled spirits), a less sweet, and rich refreshing drink was obtained by adding the palatinose condensation product of 3 to 10% as saccharide. Each of the product mixtures of Examples 2, 1 and 4 wasdissolved in an amount of 10%, calculated as the palatinose condensation product, in soda water, to which a small quantity of a flavour and 0.1% of citric acid were added. For comparison, 2.5% of sucrose were added instead of the palatinose condensation product. The amount of sucrose, 2.5%, was such as to give mild sweetness.
Eighty (80)parts of the above blend and 20 parts of ice were added to 20 parts of Shochu (distilled spirits, 250), which was then subjected to an organoleptic test by fifteen panellists. The results are as follows.
Palatinose condensation Ranking of product from preference Example 2 Example 1
Example 4
1 Sucrose 2.5% 4 Major remarks mild as a whole, easy to drink, and full of body a little too sweet, but mild and easy to drink a little too sweet, but mild and full of body no balance among tastes 36

Claims (24)

1. A palatinose condensation product composed of 2 to 6 palatinose units.
2. A palatinose condensation product composed of 2 to 4 palatinose units.
3. A palatinose condensation product hydrolysable substantially to palatinose.
4. A mixture of palatinose and a palatinose condensation product which has a reduced tendency to crystallization of palatinose as compared to a composition containing the same amount of palatinose but no palatinose condensation product.
5. A mixture of palatinose and -palatinose reaction product as claimed in any one of Claims 1 to
6. A palatinose reaction product or a mixture was claimed in Claim 5 substantially as specifically described herein with reference to the accompanying examples.
7. A process for the preparation of a palatinose condensation product in which an aqueous palatinose solution having a PH of about 3.2 to 5.
8 is heatconcentrated up to a liquid temperature of about 105 to 1700C.
37 8. A process for the preparation of a palatinose condensation product in which an aqueous palatinose solution is heat-concentrated up to a liquid temperature of about 140 to 1650C at atmospheric pressure.
9. A process for the preparation of a palatinose condensation product in which an aqueous palatinose solution is heat-concentrated up to a liquid temperature of about 105 to 1600C at pressures of about mmHg or below.
is
10. A process as claimed in any one of Claims 7 to 9 in which the pH of the aqueous palatinose solution is adjusted with one ormore less volatile organic acids.
11. A process as claimed in Claim 10 in which the acid is citric acid, malic acid, succinicacid or tartaric acid or a mixture thereof.
12. A process as claimed in any one of Claims 7 to 11 substantially as specifically described herein with reference to the accompanying examples.
13. A palatinose condensation product whenever prepared by a process as claimed in any one of Claims 7 to 12.
14. A reaction mixture obtained from a process as claimed in any one of Claims 7 to 12.
38
15. A food product containing a material as claimed in any one of Claims 1 to 6 or 13 or 14.
16. A food product as claimed in Claim 15 also containing palatinose.
17. A food product as claimed in Claim 15 substantially as specifically described herein with reference to the accompanying examples.
18. A medicament containing a material as claimed in any one of Claims 1 to 6 or 13 or 14.
19. The use of a palatinose condensation product is in the preparation of a product for oral administration to encourage Bifidobacterium.
20. A process for encouraging the proliferation of Bifidobacterium which comprises administering a material as claimed in any one of Claims 1 to 6 or 13 or 14 to an environment containing Bifidobacterium.
21. Bifidobacterium whenever produced by a process as claimed in Claim 20.
22. A composition useful in the proliferation of Bifidobacterium, containing a palatinose condensation product in an effective amount.
23. A composition as claimed in Claim 22 in which the palatinose condensation product is a mateiial as claimed in any one of Claims 1 to 6 or Claim 13 or 14.
i V 2 39
24. A composition as claimed in Claim 22 or Claim 23, containing about 0. 5 to 80% by weight, calculated on the composition, of the palatinose condensation product.
is 1 PUblISk',ed 19b13 at The 1HIOUSe. Ce-1 1-.,gh. Mc:bor-. Londw. WC1R 47P 7-7- lzu= er c0Pi.'5 may be obmneJ frcr., 7re Patent 0Mce, 7-,pn bv M1jt11)1e.x,echrliW,1.5 ltd. St Mary Cray, Kent. Con. 1 87.
GB8813095A 1987-06-04 1988-06-03 Palatinose condensation product and a process for the preparation thereof and a method for utilizing the product Expired - Lifetime GB2206582B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13902187 1987-06-04
JP63096870A JP2704627B2 (en) 1988-04-21 1988-04-21 Bifidobacterium multiplication composition

Publications (3)

Publication Number Publication Date
GB8813095D0 GB8813095D0 (en) 1988-07-06
GB2206582A true GB2206582A (en) 1989-01-11
GB2206582B GB2206582B (en) 1991-02-13

Family

ID=26438031

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8813095A Expired - Lifetime GB2206582B (en) 1987-06-04 1988-06-03 Palatinose condensation product and a process for the preparation thereof and a method for utilizing the product

Country Status (2)

Country Link
DE (1) DE3818884C2 (en)
GB (1) GB2206582B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380248A2 (en) * 1989-01-26 1990-08-01 Pfizer Inc. Modified polydextrose and process therefor
WO2004045312A1 (en) * 2002-11-18 2004-06-03 Shin Mitsui Sugar Co., Ltd. Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material
WO2014111501A1 (en) 2013-01-18 2014-07-24 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Non-cariogenic jelly confectionary

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4422819B2 (en) * 1999-06-21 2010-02-24 株式会社ロッテ Deodorant, food and drink containing the same, composition for oral cavity and toiletry product
DE10104055A1 (en) * 2001-01-31 2002-08-14 Suedzucker Ag Use of carbohydrates to eliminate intestinal infections in animals
DE10262018B4 (en) * 2002-06-13 2007-09-06 Südzucker AG Mannheim/Ochsenfurt Compositions, foodstuffs, food and beverages, confectionery, animal feed, dietary special nutrition, child nutrition, sweeteners and pharmaceutical compositions containing condensed palatinose
DE10242062B4 (en) * 2002-09-11 2007-02-15 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Hydrogenated condensed Palatinose, process for their preparation and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422294A (en) * 1974-04-05 1976-01-21 Pfizer Saccharide polycondensation
JPS5836959B2 (en) * 1980-08-21 1983-08-12 三井製糖株式会社 Method for producing palatinose using immobilized α-glucosyltransferase
JPS5771377A (en) * 1980-10-23 1982-05-04 Mitsui Seito Kk Sweetening agent having low cariogenicity
JPS62294081A (en) * 1986-06-12 1987-12-21 Kato Shoichi Proliferation promoting substance for bifidus bacteria
JPS63294081A (en) * 1987-05-26 1988-11-30 Matsushita Electric Ind Co Ltd Image pickup device

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380248A2 (en) * 1989-01-26 1990-08-01 Pfizer Inc. Modified polydextrose and process therefor
EP0380248A3 (en) * 1989-01-26 1990-10-17 Pfizer Inc. Modified polydextrose and process therefor
WO2004045312A1 (en) * 2002-11-18 2004-06-03 Shin Mitsui Sugar Co., Ltd. Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material
US9017745B2 (en) 2002-11-18 2015-04-28 Mitsui Sugar Co., Ltd. Method of using isomaltulose to suppress body fat accumulation
US9017744B2 (en) 2002-11-18 2015-04-28 Mitsui Sugar Co., Ltd. Method of using isomaltulose to suppress blood glucose level increase
WO2014111501A1 (en) 2013-01-18 2014-07-24 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Non-cariogenic jelly confectionary
EA032535B1 (en) * 2013-01-18 2019-06-28 Зюдцукер Актингезелльшафт Маннхайм/Оксенфурт Non-cariogenic jelly confectionary

Also Published As

Publication number Publication date
DE3818884A1 (en) 1989-01-05
GB2206582B (en) 1991-02-13
GB8813095D0 (en) 1988-07-06
DE3818884C2 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
US5698437A (en) Agent for promoting the proliferation of bifidobacterium
JP3182679B2 (en) Non-reducing oligosaccharides, their production and use
JP3066070B2 (en) Branched fructo-oligosaccharides, process for their preparation and use of products containing them
GB2097004A (en) Crystalline anhydrous maltitol
GB2162524A (en) Crystalline maltose
GB2104525A (en) New a-glycosyl glycyrrhizins having sweetening and pharmacological properties
US20210120855A1 (en) Mixed saccharide composition comprising maltooligosaccharide
JP2006502103A (en) Condensed palatinose and method for producing the same
US5585480A (en) Hydrogenated fructooligosaccharides
US7183265B2 (en) Powdery product comprising crystalline β-maltose monohydrate, its preparation, and uses
WO2002088374A1 (en) Process for producing isomaltose and use thereof
GB2206582A (en) Palatinose condensation product and a process for the preparation thereof and a method for utilizing the product
JPS6251584B2 (en)
JP3142906B2 (en) Food and drink, taste, cosmetics and pharmaceuticals, and method for producing starch sugar-containing composition
JPH05252974A (en) Production of turanose and its use
JP2704627B2 (en) Bifidobacterium multiplication composition
JPS6251585B2 (en)
JP2639386B2 (en) Palatinose condensate, method for producing and using the same
JP3746065B2 (en) β-maltose hydrous crystal-containing powder, its production method and use
JP3806142B2 (en) β-maltose hydrous crystal-containing powder, its production method and use
JPS615760A (en) Sweetener having high sweetness and preparation of low-calorific food and drink using same
JP3746064B2 (en) β-maltose hydrous crystal-containing powder, its production method and use
JP3746066B2 (en) β-maltose hydrous crystal-containing powder, its production method and use
JP3764472B2 (en) β-maltose hydrous crystal-containing powder, its production method and use
JPS6328369A (en) Food and drink and preparation thereof

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20070603